Limit search to items available for checkout
2008 results found. Sorted by relevance | date | title .
E-BOOK
Title Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials : proceedings of a workshop / Karen M. Anderson and Steve Olson, rapporteurs ; Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities, Board on Population Health and Public Health Practice, Health and Medicine Division ; the National Academies of Sciences, Engineering, Medicine.
Imprint Washington, DC : The National Academies Press, [2016]

Copies/Volumes

LOCATION CALL # STATUS
 Internet  Electronic Book    AVAILABLE
Description 1 online resource (1 PDF file (xiii, 69 pages)) : illustrations
Series Online access: NCBI NCBI Bookshelf.
Online access: National Academy of Sciences National Academies Press.
Bibliog. Includes bibliographical references.
Note Available only to authorized UTEP users.
This activity was supported by the Aetna Foundation, Health Resources and Services Administration, Kaiser Permanente, The Kresge Foundation, Merck & Co., Inc., Methodist Health Ministries, and Office of Minority Health, U.S. Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
Online resource; title from PDF title page (viewed October 18, 2016).
Subject Clinical trials.
Discrimination in medical care.
Health services accessibility.
Clinical Trials as Topic.
Communication Barriers.
Ethnic Groups.
Healthcare Disparities.
Minority Groups.
Patient Selection.
Women.
United States.
Genre Congress.
Conference papers and proceedings.
Contents Introduction and highlights of the workshop -- Historical perspectives and context -- Scientific issues: clinically meaningful inclusion -- Recruitment and retention issues: patient, provider, institutional, and system barriers -- Potential best practices and policy options.
Summary Even as the U.S. population becomes steadily more diverse, minorities and women remain underrepresented in clinical trials to develop new drugs and medical devices. Although progress in increasing minority participation in clinical trials has occurred, participation rates do not fully represent the overall population of minorities in the United States. This underrepresentation threatens the health of both these populations and the general population, since greater minority representation could reveal factors that affect health in all populations. Federal legislation has sought to increase the representation of minorities and women in clinical trials, but legislation by itself has not been sufficient to overcome the many barriers to greater participation. Only much broader changes will bring about the meaningful participation of all population groups in the clinical research needed to improve health. To examine the barriers to participation in clinical trials and ways of overcoming those barriers, the National Academies of Sciences, Engineering, and Medicine held a workshop in April 2015. This publication summarizes the presentations and discussions from the workshop.
Other Author Olson, Steve, 1956- rapporteur.
National Academies of Sciences, Engineering, and Medicine (U.S.). Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities.
National Academies of Sciences, Engineering, and Medicine (U.S.), issuing body.
Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials (Workshop) (2015 : Washington, D.C.)
Other Title Print version: Anderson, Karen M. Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials. Washington, D.C. : National Academies Press, 2016